FSD Pharma Phase II COVID-19 trial gets go-ahead September 30, 2020 Auto Bot Clinical Development 0 The companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.
